Advair.pdf - ACTIVE LEARNING TEMPLATE Medication STUDENT...

This preview shows page 1 out of 1 page.

Unformatted text preview: ACTIVE LEARNING TEMPLATE: Medication STUDENT NAME______________________________________ Advair MEDICATION___________________________________________________________________________ REVIEW MODULE CHAPTER____________ CATEGORY CLASS__Corticosteroid _____________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Potent, locally acting anti-inflammatory and immune modifier Therapeutic Use Decreases frequency and severity of asthma attacks. Complications headache, dizziness. dysphonia, hoarseness, oropharyngeal fungal infections, nasal stuffiness, rhinorrhea, sinusitis. bronchospasm, cough, upper respiratory tract infection, wheezing. diarrhea. adrenal suppression (high-dose, long-term therapy only),pbone mineral density, Cushing’s syndrome. muscle pain. hypersensitivity reactions including ANAPHYLAXIS, LARYNGEAL EDEMA, URTICARIA, and BRONCHOSPASM, CHURG-STRAUSS SYNDROME, fever. Contraindications/Precautions : Hypersensitivity (contains propellants); Acute attack of asthma/status asthmaticus. Use Cautiously in: Active untreated infections; Diabetes or glaucoma; Underlying immunosuppression (due to disease or concurrent therapy); Systemic corticosteroid therapy (should not be abruptly discontinued when inhalable therapy is started; additional corticosteroids needed in stress or trauma); Hepatic dysfunction; Severe milk protein allergy (powder for oral inhalation contains lactose); Interactions Drug-Drug: Strong CYP3A4 inhibitors, including ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir,saquinavir, and telithromycinpmetabolism andqlevels; concurrent use not recommended.. Evaluation of Medication Effectiveness ●Management of the symptoms of chronic asthma ACTIVE LEARNING TEMPLATES Medication Administration Inhaln (Adults and Children 12 yr): Patients whose previous asthma therapy included bronchodilators alone—100 mcg twice daily initially, may bequp to 500 mcg twice daily; Patients whose previous therapy included other inhaled corticosteroids— 100– 250 mcg twice daily initially, may bequp to 500 mcg twice daily; Patients whose previous therapy included oral corticosteroids—500– 1000 mcg twice daily Nursing Interventions Monitor respiratory status and lung sounds. Assess pulmonary function tests periodically during and for several months after a transfer from systemic to inhalation corticosteroids. Monitor for signs and symptoms of hypersensitivity reactions Client Education Advise patient to take medication as directed. If a dose is missed, take as soon as remembered unless almost time for next dose. Instruct patient to read the Patient Information and Instructions for Use before using and with each Rx refill, in case of new information. Advise patient not to discontinue medication without consulting health care professional; gradual decrease is required. ● Advise patients using inhalation corticosteroids and bronchodilator to use bronchodilator first and to allow 5 min to elapse before administering the corticosteroid, unless otherwise directed by health care professional Therapeutic Procedure  A7 ...
View Full Document

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture